Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata patients often have autoimmune disorders, especially thyroid issues.

Alopecia areata patients experience more psychological distress, linked to certain neurotrophin levels.

Alopecia areata patients have a higher risk of blood clots.

Alopecia Areata patients have too many Firmicutes and too few Bacteroides in their gut.

Monthly oral corticosteroid pulses effectively treat widespread alopecia areata in young patients.

Diphenylcyclopropenone's effectiveness and safety for alopecia areata are unclear.

Baricitinib helps patients with severe alopecia areata regrow hair.

People with severe alopecia areata often have lower vitamin D levels and may have other autoimmune or allergic conditions.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Atopic dermatitis in kids with alopecia areata can predict poor response to topical immunotherapy.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Access to JAK inhibitor therapy for alopecia areata patients is difficult, especially for racial minorities.

Alopecia areata may lead to hearing loss.

A patient with a rare chromosome condition also had a rare type of hair loss.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Serum from alopecia patients does not stop hair growth in grafted skin on mice.

Illness perception affects mental health and quality of life in Chinese alopecia patients.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

People with alopecia areata may be more likely to have a certain type of hearing loss.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Younger patients with severe alopecia areata often have nail problems.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

The main goal for new Alopecia Areata treatments should be significant improvement in scalp hair growth.

A patient with leukemia/lymphoma also had multiple autoimmune diseases, suggesting a link between them.